Education
About Us
Working with TipRanks
Follow Us
Acro Biomedical Co Ltd (ACBM)
OTHER OTC:ACBM
ACBM Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $4.00
Previous CloseN/A
Volume100.00
Average Volume (3M)0.00
Market Cap
$42.03K
Enterprise ValueN/A
Total Cash (Recent Filing)$26.00
Total Debt (Recent Filing)$255.30K
Price to Earnings (P/E)―
Beta-0.97
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding60,042,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)-0.20
Price to Sales (P/S)0.00
P/FCF Ratio-1.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Acro Biomedical Co News
ACBM FAQ
What was Acro Biomedical Co Ltd’s price range in the past 12 months?
Acro Biomedical Co Ltd lowest stock price was <$0.01 and its highest was $4.00 in the past 12 months.
What is Acro Biomedical Co Ltd’s market cap?
Acro Biomedical Co Ltd’s market cap is $42.03K.
When is Acro Biomedical Co Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Acro Biomedical Co Ltd’s earnings last quarter?
Currently, no data Available
Is Acro Biomedical Co Ltd overvalued?
According to Wall Street analysts Acro Biomedical Co Ltd’s price is currently Overvalued.
Does Acro Biomedical Co Ltd pay dividends?
Acro Biomedical Co Ltd does not currently pay dividends.
What is Acro Biomedical Co Ltd’s EPS estimate?
Acro Biomedical Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Acro Biomedical Co Ltd have?
Acro Biomedical Co Ltd has 60,042,000 shares outstanding.
What happened to Acro Biomedical Co Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Acro Biomedical Co Ltd?
Currently, no hedge funds are holding shares in ACBM
Company Description
Acro Biomedical Co Ltd
Acro Biomedical Co., Ltd. engages in developing and marketing of nutritional products. It sells cordycepin and cordyceps powder, a fungus used in traditional Chinese medicine. The company was formerly known as Killer Waves Hawaii, Inc. and changed its name to Acro Biomedical Co., Ltd. in January 2017. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana.
Technical Analysis
Biodexa Pharmaceuticals
―
TNF Pharmaceuticals
―
Salarius Pharmaceuticals
―
Scinai Immunotherapeutics
―
Oragenics
―